ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis
FRA:ACT - Deutsche Boerse Ag - DE000A2YNT30 - Common Stock - Currency: EUR
Taking everything into account, ACT scores 7 out of 10 in our fundamental rating. ACT was compared to 65 industry peers in the Chemicals industry. Both the health and profitability get an excellent rating, making ACT a very profitable company, without any liquidiy or solvency issues. ACT is not valued too expensively and it also shows a decent growth rate. These ratings could make ACT a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
ACT had positive earnings in the past year.
In the past year ACT had a positive cash flow from operations.
Each year in the past 5 years ACT has been profitable.
Of the past 5 years ACT 4 years had a positive operating cash flow.
1.2 Ratios
ACT has a better Return On Assets (11.18%) than 96.92% of its industry peers.
ACT's Return On Equity of 26.31% is amongst the best of the industry. ACT outperforms 98.46% of its industry peers.
ACT's Return On Invested Capital of 14.95% is amongst the best of the industry. ACT outperforms 96.92% of its industry peers.
ACT had an Average Return On Invested Capital over the past 3 years of 12.06%. This is significantly above the industry average of 6.60%.
The 3 year average ROIC (12.06%) for ACT is below the current ROIC(14.95%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.18% | ||
| ROE | 26.31% | ||
| ROIC | 14.95% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
1.3 Margins
ACT has a better Profit Margin (9.76%) than 83.08% of its industry peers.
ACT's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 14.16%, ACT is doing good in the industry, outperforming 80.00% of the companies in the same industry.
ACT's Operating Margin has improved in the last couple of years.
ACT has a Gross Margin of 64.27%. This is amongst the best in the industry. ACT outperforms 95.38% of its industry peers.
ACT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.16% | ||
| PM (TTM) | 9.76% | ||
| GM | 64.27% |
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ACT is creating value.
The number of shares outstanding for ACT has been reduced compared to 1 year ago.
ACT has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, ACT has an improved debt to assets ratio.
2.2 Solvency
ACT has an Altman-Z score of 5.22. This indicates that ACT is financially healthy and has little risk of bankruptcy at the moment.
ACT has a better Altman-Z score (5.22) than 89.23% of its industry peers.
The Debt to FCF ratio of ACT is 0.85, which is an excellent value as it means it would take ACT, only 0.85 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ACT (0.85) is better than 96.92% of its industry peers.
ACT has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.21, ACT is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 0.85 | ||
| Altman-Z | 5.22 |
ROIC/WACC2.14
WACC6.98%
2.3 Liquidity
A Current Ratio of 2.48 indicates that ACT has no problem at all paying its short term obligations.
ACT has a better Current ratio (2.48) than 73.85% of its industry peers.
A Quick Ratio of 1.52 indicates that ACT should not have too much problems paying its short term obligations.
ACT's Quick ratio of 1.52 is fine compared to the rest of the industry. ACT outperforms 72.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.48 | ||
| Quick Ratio | 1.52 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 44.79% over the past year.
The Earnings Per Share has been growing by 24.60% on average over the past years. This is a very strong growth
ACT shows a small growth in Revenue. In the last year, the Revenue has grown by 1.59%.
The Revenue has been growing by 8.06% on average over the past years. This is quite good.
EPS 1Y (TTM)44.79%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%20.45%
Revenue 1Y (TTM)1.59%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%-3.59%
3.2 Future
The Earnings Per Share is expected to grow by 14.11% on average over the next years. This is quite good.
Based on estimates for the next years, ACT will show a small growth in Revenue. The Revenue will grow by 6.02% on average per year.
EPS Next Y14.33%
EPS Next 2Y13.05%
EPS Next 3Y16.33%
EPS Next 5Y14.11%
Revenue Next Year3.58%
Revenue Next 2Y5.79%
Revenue Next 3Y8.13%
Revenue Next 5Y6.02%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 23.74, the valuation of ACT can be described as rather expensive.
ACT's Price/Earnings ratio is in line with the industry average.
ACT's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.29.
A Price/Forward Earnings ratio of 20.28 indicates a rather expensive valuation of ACT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ACT is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.17, ACT is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.74 | ||
| Fwd PE | 20.28 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ACT is on the same level as its industry peers.
70.77% of the companies in the same industry are more expensive than ACT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.66 | ||
| EV/EBITDA | 12.6 |
4.3 Compensation for Growth
ACT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ACT has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ACT's earnings are expected to grow with 16.33% in the coming years.
PEG (NY)1.66
PEG (5Y)0.97
EPS Next 2Y13.05%
EPS Next 3Y16.33%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.46%, ACT has a reasonable but not impressive dividend return.
ACT's Dividend Yield is comparable with the industry average which is at 3.09.
Compared to the average S&P500 Dividend Yield of 2.38, ACT is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.46% |
5.2 History
The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
ACT pays out 22.58% of its income as dividend. This is a sustainable payout ratio.
The dividend of ACT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP22.58%
EPS Next 2Y13.05%
EPS Next 3Y16.33%
FRA:ACT (6/3/2025, 4:46:17 PM)
132
+1.4 (+1.07%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners25.86%
Inst Owner ChangeN/A
Ins Owners46.03%
Ins Owner ChangeN/A
Market Cap1.34B
Analysts86
Price Target109.63 (-16.95%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.46% |
Yearly Dividend1.2
Dividend Growth(5Y)6%
DP22.58%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.7%
PT rev (3m)42.77%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)6.16%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.2%
Revenue NY rev (3m)-1.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.74 | ||
| Fwd PE | 20.28 | ||
| P/S | 2.42 | ||
| P/FCF | 21.66 | ||
| P/OCF | 12.78 | ||
| P/B | 6.54 | ||
| P/tB | 6.66 | ||
| EV/EBITDA | 12.6 |
EPS(TTM)5.56
EY4.21%
EPS(NY)6.51
Fwd EY4.93%
FCF(TTM)6.09
FCFY4.62%
OCF(TTM)10.33
OCFY7.82%
SpS54.44
BVpS20.19
TBVpS19.83
PEG (NY)1.66
PEG (5Y)0.97
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.18% | ||
| ROE | 26.31% | ||
| ROCE | 20.74% | ||
| ROIC | 14.95% | ||
| ROICexc | 17.85% | ||
| ROICexgc | 18.06% | ||
| OM | 14.16% | ||
| PM (TTM) | 9.76% | ||
| GM | 64.27% | ||
| FCFM | 11.2% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ROICexc(3y)13.35%
ROICexc(5y)11.55%
ROICexgc(3y)13.5%
ROICexgc(5y)11.66%
ROCE(3y)16.73%
ROCE(5y)14.74%
ROICexcg growth 3Y25.57%
ROICexcg growth 5Y18.04%
ROICexc growth 3Y25.41%
ROICexc growth 5Y17.9%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
F-Score7
Asset Turnover1.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 0.85 | ||
| Debt/EBITDA | 0.41 | ||
| Cap/Depr | 163.77% | ||
| Cap/Sales | 7.78% | ||
| Interest Coverage | 33.75 | ||
| Cash Conversion | 100.34% | ||
| Profit Quality | 114.74% | ||
| Current Ratio | 2.48 | ||
| Quick Ratio | 1.52 | ||
| Altman-Z | 5.22 |
F-Score7
WACC6.98%
ROIC/WACC2.14
Cap/Depr(3y)118.98%
Cap/Depr(5y)119.68%
Cap/Sales(3y)5.65%
Cap/Sales(5y)6.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.79%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%20.45%
EPS Next Y14.33%
EPS Next 2Y13.05%
EPS Next 3Y16.33%
EPS Next 5Y14.11%
Revenue 1Y (TTM)1.59%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%-3.59%
Revenue Next Year3.58%
Revenue Next 2Y5.79%
Revenue Next 3Y8.13%
Revenue Next 5Y6.02%
EBIT growth 1Y36.94%
EBIT growth 3Y28.68%
EBIT growth 5Y21.47%
EBIT Next Year48.64%
EBIT Next 3Y26.44%
EBIT Next 5Y19.11%
FCF growth 1Y19.06%
FCF growth 3Y62.42%
FCF growth 5Y94.14%
OCF growth 1Y44.69%
OCF growth 3Y34.7%
OCF growth 5Y19.23%